How was the value of Dale B. Wolf’s Molina Healthcare share grant determined?

The quarterly equity grant was set at $55,000, based on Molina Healthcare’s closing stock price. On July 1, 2026, the closing price was $232.55 per share, which mathematically resulted in a grant of 237 shares as director compensation.

Molina Healthcare (MOH) director receives 237-share quarterly equity award

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

WOLF DALE B reported acquisition or exercise transactions in this Form 4 filing.

Molina Healthcare director Dale B. Wolf received an equity grant of 237 shares of common stock, awarded through a trust, as part of his board compensation. The grant was made under the 2025 Equity Incentive Plan, valued at $55,000 based on the $232.55 closing price on July 1, 2026, bringing indirect holdings to 15,633 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider WOLF DALE B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	237	$232.55	$55K

Holdings After Transaction: Common Stock — 15,633 shares (Indirect, Held by Trust)

Footnotes (1)

Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares. Represents the closing price of the Issuer's common stock on July 1, 2026. Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee.

Key Figures

Quarterly equity grant: 237 shares Grant valuation: $55,000 Annual director equity award: $220,000 +2 more

5 metrics

Quarterly equity grant 237 shares Common stock granted on July 1, 2026

Grant valuation $55,000 Quarterly portion of director annual equity award

Annual director equity award $220,000 Total yearly equity compensation per director

Stock closing price $232.55 per share Molina Healthcare closing price on July 1, 2026

Holdings after grant 15,633 shares Indirect holdings via revocable trust after award

Key Terms

2025 Equity Incentive Plan, annual equity award, closing price, Revocable Trust

4 terms

2025 Equity Incentive Plan financial

"Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director."

annual equity award financial

"The aggregate dollar value of the annual equity award to each director was set at $220,000..."

closing price financial

"The closing price of the Issuer's common stock on July 1, 2026 was $232.55..."

Revocable Trust financial

"Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee."

A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:54 PM Accepted by SEC EDGAR 07/02/2026 - 04:53 PM

FAQ

What insider transaction did Molina Healthcare (MOH) report for Dale B. Wolf?

Dale B. Wolf received 237 shares of Molina Healthcare common stock as an equity grant. The award was part of his compensation for serving as a director under the company’s 2025 Equity Incentive Plan, delivered indirectly through a revocable trust structure.

What is the total annual equity compensation for Molina Healthcare directors?

The annual equity award for each Molina Healthcare director was set at $220,000. One quarter of this amount, or $55,000, is granted on the first day of each quarter, calculated using the company’s closing stock price on that grant date.

How many Molina Healthcare shares does Dale B. Wolf hold after this grant?

After receiving the 237-share grant, Dale B. Wolf’s indirect holdings total 15,633 shares of Molina Healthcare common stock. These shares are held through the Dale B. Wolf Revocable Trust, for which he serves as the sole trustee with authority over the assets.

Through what entity are Dale B. Wolf’s Molina Healthcare shares held?

The shares are held by the Dale B. Wolf Revocable Trust. Dale B. Wolf is the sole trustee of this trust, meaning he oversees and controls the trust’s assets, including the Molina Healthcare common stock received as director equity compensation awards.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WOLF DALE B

(Last)

(First)

(Middle)

200 OCEANGATE

SUITE 100

(Street)

LONG BEACH

CALIFORNIA

90802

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/01/2026		A⁽¹⁾		237⁽²⁾	A	$232.55⁽³⁾	15,633	I	Held by Trust⁽⁴⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.

3. Represents the closing price of the Issuer's common stock on July 1, 2026.

4. Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee.

Remarks:

	Jeff D. Barlow, by power of attorney for Dale B. Wolf.	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR